Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hana Biologics is a regenerative medicine company based in Houston, Texas, that specializes in the development and distribution of human birth tissue-derived allografts. The company's product line includes amniotic fluid, umbilical cord tissue, and amniotic membrane products, such as HanaPure, HanaCord, and HanaMatrix, which are processed using proprietary techniques to preserve essential biological components like growth factors and cytokines. These biologics are designed for use in various clinical applications, including orthopedics, podiatry, and wound management, to facilitate tissue repair and reduce inflammation. Hana Biologics operates as a commercial-stage entity, providing healthcare professionals with minimally invasive options for regenerative therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hana Biologics.